Immunomodulatory effects of Lactobacillus strains: Emphasis on their effects on cancer cells

Immunotherapy

Volumn 7, Issue 12, 2015, Pages 1307-1329

  Abedin Do, Atieh ^a   Taherian Esfahani, Zahra ^a   Ghafouri Fard, Soudeh ^a   Ghafouri Fard, Somayyeh ^a   Motevaseli, Elahe ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

cancer; immunotherapy; lactobacilli; probiotic

Indexed keywords

BACTERIAL VACCINE; CANCER VACCINE; CYTOKINE; PROBIOTIC AGENT;

BACTERIAL STRAIN; BLADDER CANCER; CANCER CELL; CANCER IMMUNOTHERAPY; CANCER PREVENTION; CYTOKINE PRODUCTION; CYTOTOXICITY; DRUG DELIVERY SYSTEM; HUMAN; IMMUNOMODULATION; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS GASSERI; LACTOBACILLUS HELVETICUS; LACTOBACILLUS JOHNSONII; LACTOBACILLUS PARACASEI; LACTOBACILLUS PLANTARUM; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; LACTOBACILLUS SALIVARIUS; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; BONE MARROW CELL; DENDRITIC CELL; IMMUNE SYSTEM; IMMUNOLOGY; IMMUNOTHERAPY; METABOLISM; MICROBIOLOGY; MONONUCLEAR CELL; NEOPLASMS; PROCEDURES;

ANIMALS; CYTOKINES; DENDRITIC CELLS; HUMANS; IMMUNE SYSTEM; IMMUNOTHERAPY; LACTOBACILLUS; LEUKOCYTES, MONONUCLEAR; MYELOID CELLS; NEOPLASMS; PROBIOTICS;

EID: 84948991169     PISSN: 1750743X     EISSN: 17507448     Source Type: Journal    
DOI: 10.2217/imt.15.92     Document Type: Review

References (127)

1. Ghafouri-Fard S, Modarressi MH. Expression of cancer-testis genes in brain tumors. implications for cancer immunotherapy. Immunotherapy 4(1), 59-75 (2012).
2. Ghafouri-Fard S, Ghafouri-Fard S. Immunotherapy in nonmelanoma skin cancer. Immunotherapy 4(5), 499-510 (2012).
3. Ghafouri-Fard S, Ghafouri-Fard S. siRNA and cancer immunotherapy. Immunotherapy 4(9), 907-917 (2012).
4. Ghafouri-Fard S, Shamsi R, Seifi-Alan M et al. Cancertestis genes as candidates for immunotherapy in breast cancer. Immunother. 6(2), 165-179 (2014).
5. Linnebacher M, Maletzki C, Klier U, Klar E. Bacterial immunotherapy of gastrointestinal tumors. Langenbecks Arch. Surg. 397(4), 557-568 (2012).
6. Compare D, Nardone G. Contribution of gut microbiota to colonic and extracolonic cancer development. Digestive Diseases (Basel, Switzerland) 29(6), 554-561 (2011).
7. Goldszmid RS, Dzutsev A, Trinchieri G. Host immune response to infection and cancer: unexpected commonalities. Cell Host Microbe 15(3), 295-305 (2014).
8. Hebert EF, Divi RL, Verma M. Microbiome analysis: trends in cancer epidemiology, challenges and opportunities. Int. J. Cancer Res. Mol. Mech. 1(1), (2015).
9. Viaud S, Saccheri F, Mignot G et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 342(6161), 971-976 (2013).
10. Baricault L, Denariaz G, Houri JJ et al. Use of HT-29, a cultured human colon cancer cell line, to study the effect of fermented milks on colon cancer cell growth and differentiation. Carcinogenesis 16(2), 245-252 (1995).
11. Raman M, Ambalam P, Kondepudi KK et al. Potential of probiotics, prebiotics and synbiotics for management of colorectal cancer. Gut Microbes 4(3), 181-192 (2013).
12. Chen Y, Zhao Y, Cheng Q, Wu D, Liu H. The role of intestinal microbiota in acute graft-versus-host disease. J. Immunol. Res. 2015, 145859 (2015).
13. Bron PA, Van Baarlen P, Kleerebezem M. Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa. Nat. Rev. Microbiol. 10(1), 66-78 (2012).
14. Femia AP, Luceri C, Dolara P et al. Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis 23(11), 1953-1960 (2002).
15. Rafter J, Bennett M, Caderni G et al. Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am. J. Clin. Nutr. 85(2), 488-496 (2007).
16. Zabihollahi R, Motevaseli E, Sadat SM et al. Inhibition of HIV and HSV infection by vaginal lactobacilli in vitro and in vivo. Daru 20(1), 53 (2012).
17. Tlaskalova-Hogenova H, Tuckova L, Lodinova-Zadnikova R et al. Mucosal immunity. its role in defense and allergy. Int. Arch. Allergy Immunol. 128(2), 77-89 (2002).
18. Azam R, Ghafouri-Fard S, Tabrizi M et al. Lactobacillus acidophilus and Lactobacillus crispatus culture supernatants downregulate expression of cancer-testis genes in the MDA-MB-231 cell line. Asian Pac. J. Cancer Prev. 15(10), 4255-4259 (2014).
19. Motevaseli E, Shirzad M, Akrami SM et al. Normal and tumour cervical cells respond differently to vaginal lactobacilli, independent of pH and lactate. J. Med Microbiol. 62(Pt 7), 1065-1072 (2013).
20. Motevaseli E, Shirzad M, Raoofian R et al. Differences in vaginal lactobacilli composition of Iranian healthy and bacterial vaginosis infected women. A comparative analysis of their cytotoxic effects with commercial vaginal probiotics. Iran. Red Crescent Med. J. 15(3), 199-206 (2013).
21. Ahmadi MA, Ebrahimi MT, Mehrabian S et al. Antimutagenic and anticancer effects of lactic acid bacteria isolated from Tarhana through Ames test and phylogenetic analysis by 16S rDNA. Nutr. Cancer 66(8), 1406-1413 (2014).
22. Dugas B, Mercenier A, Lenoir-Wijnkoop I et al. Immunity and probiotics. Immunol. Today 20(9), 387-390 (1999).
23. Zhang M, Wang F, Jiang L et al. Lactobacillus salivarius REN inhibits rat oral cancer induced by 4-nitroquioline 1-oxide. Cancer Prev. Res. (Phila.) 6(7), 686-694 (2013).
24. Oh HY, Kim BS, Seo SS et al. The association of uterine cervical microbiota with an increased risk for cervical intraepithelial neoplasia in Korea. Clin. Microbiol. Infect. (2015).
25. Xing J, Wang G, Zhang Q et al. Determining antioxidant activities of lactobacilli cell-free supernatants by cellular antioxidant assay. a comparison with traditional methods. PloS ONE 10(3), e0119058 (2015).
26. Wells JM. Immunomodulatory mechanisms of lactobacilli. Microb. Cell Fact. 10(Suppl. 1), S17 (2011).
27. Isolauri E, Joensuu J, Suomalainen H et al. Improved immunogenicity of oral D x RRV reassortant rotavirus vaccine by Lactobacillus casei GG. Vaccine 13(3), 310-312 (1995).
28. Davidson LE, Fiorino AM, Snydman DR, Hibberd PL. Lactobacillus GG as an immune adjuvant for live-attenuated influenza vaccine in healthy adults: a randomized doubleblind placebo-controlled trial. Eur. J. Clin. Nutr. 65(4), 501-507 (2011).
29. Licciardi PV, Tang ML. Vaccine adjuvant properties of probiotic bacteria. Discov. Med. 12(67), 525-533 (2011).
30. Sun J, Shi YH, Le GW, Ma XY. Distinct immune response induced by peptidoglycan derived from Lactobacillus sp. World J. Gastroenterol. 11(40), 6330-6337 (2005).
31. Horinaka M, Yoshida T, Kishi A et al. Lactobacillus strains induce TRAIL production and facilitate natural killer activity against cancer cells. FEBS Lett. 584(3), 577-582 (2010).
32. Chon H, Choi B, Jeong G et al. Suppression of proinflammatory cytokine production by specific metabolites of Lactobacillus plantarum 10hk2 via inhibiting NF-kappaB and p38 MAPK expressions. Comp. Immunol. Microbiol. Infect. Dis. 33(6), e41-e49 (2010).
33. Chon H, Choi B, Lee E et al. Immunomodulatory effects of specific bacterial components of Lactobacillus plantarum KFCC11389P on the murine macrophage cell line RAW 264.7. J. Appl. Microbiol. 107(5), 1588-1597 (2009).
34. Picchietti S, Fausto AM, Randelli E et al. Early treatment with Lactobacillus delbrueckii strain induces an increase in intestinal T-cells and granulocytes and modulates immunerelated genes of larval Dicentrarchus labrax (L.). Fish Shellfish Immunol. 26(3), 368-376 (2009).
35. Duan J-L, He S-P, Yang G et al. Effect of Lactobacillus delbrueckii on jejunum innate immune-related gene expression in mice. J. Zhejiang Univ. Sci. B 1(1), (1998).
36. Galdeano CM, Perdigon G. The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity. Clin. Vaccine Immunol. 13(2), 219-226 (2006).
37. Baken KA, Ezendam J, Gremmer ER et al. Evaluation of immunomodulation by Lactobacillus casei Shirota. immune function, autoimmunity and gene expression. Int. J. Food Microbiol.112(1), 8-18 (2006).
38. Kim Y-G, Ohta T, Takahashi T et al. Probiotic Lactobacillus casei activates innate immunity via NF-B and p38 MAP kinase signaling pathways. Microbes Infect. 8(4), 994-1005 (2006).
39. Panigrahi A, Kiron V, Satoh S et al. Immune modulation and expression of cytokine genes in rainbow trout Oncorhynchus mykiss upon probiotic feeding. Dev. Comp. Immunol. 31(4), 372-382 (2007).
40. Fang SB, Shih HY, Huang CH et al. Live and heat-killed Lactobacillus rhamnosus GG upregulate gene expression of pro-inflammatory cytokines in 5-fluorouracil-pretreated Caco-2 cells. Support. Care Cancer 22(6), 1647-1654 (2014).
41. Wagner RD, Johnson SJ. Probiotic Lactobacillus and estrogen effects on vaginal epithelial gene expression responses to Candida albicans. J. Biomed. Sci. 19, 58 (2012).
42. Christensen HR, Frokiaer H, Pestka JJ. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J. Immunol. 168(1), 171-178 (2002).
43. Knutson KL, Disis ML. Tumor antigen-specific T helper cells in cancer immunity and immunotherapy. Cancer Immunol. Immunother. 54(8), 721-728 (2005).
44. Mohamadzadeh M, Olson S, Kalina WV et al. Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc. Natl Acad. Sci. USA 102(8), 2880-2885 (2005).
45. Konstantinov SR, Smidt H, De Vos WM et al. S layer protein A of Lactobacillusacidophilus NCFM regulates immature dendritic cell and T cell functions. Proc. Natl Acad. Sci. USA 105(49), 19474-19479 (2008).
46. Kitazawa H, Ino T, Kawai Y et al. A novel immunostimulating aspect of Lactobacillus gasseri: induction of "Gasserokine" as chemoattractants for macrophages. Int. J. Food Microbiol. 77(1-2), 29-38 (2002).
47. Vincenti JE. The influence of cell-free Lactobacillus rhamnosus GG supernatant on the phagocytic activity of macrophages. Biosci. Horizons 3(2), 105-112 (2010).
48. Capital Em CVV, Lazarenko LM, Sichel LM et al. The role of beneficial bacteria wall elasticity in regulating innate immune response. EPMA J 6(1), 13 (2015).
49. Lamagna C, Aurrand-Lions M, Imhof BA. Dual role of macrophages in tumor growth and angiogenesis. J. Leukoc. Biol. 80(4), 705-713 (2006).
50. Shida K, Makino K, Morishita A et al. Lactobacillus casei inhibits antigen-induced IgE secretion through regulation of cytokine production in murine splenocyte cultures. Int. Arch. Allergy Immunol. 115(4), 278-287 (1998).
51. Miettinen M, Matikainen S, Vuopio-Varkila J et al. Lactobacilli and streptococci induce interleukin-12 (IL-12), IL-18, and gamma interferon production in human peripheral blood mononuclear cells. Infect. Immun. 66(12), 6058-6062 (1998).
52. Pathmakanthan S, Li CK, Cowie J, Hawkey CJ. Lactobacillus plantarum 299: beneficial in vitro immunomodulation in cells extracted from inflamed human colon. J Gastroenterol. Hepatol. 19(2), 166-173 (2004).
53. Van Hemert S, Meijerink M, Molenaar D et al. Identification of Lactobacillus plantarum genes modulating the cytokine response of human peripheral blood mononuclear cells. BMC Microbiol. 10, 293 (2010).
54. Shyu PT, Oyong GG, Cabrera EC. Cytotoxicity of probiotics from Philippine commercial dairy products on cancer cells and the effect on expression of cfos and cjun early apoptoticpromoting genes and Interleukin-1 beta and Tumor Necrosis Factor-alpha proinflammatory cytokine genes. Biomed. Res. Int. 2014, 491740 (2014).
55. Biffi A, Coradini D, Larsen R et al. Antiproliferative effect of fermented milk on the growth of a human breast cancer cell line. Nutr. Cancer 28(1), 93-99 (1997).
56. Lightfoot YL, Yang T, Sahay B, Mohamadzadeh M. Targeting aberrant colon cancer-specific DNA methylation with lipoteichoic acid-deficient Lactobacillus acidophilus. Gut Microbes 4(1), 84-88 (2013).
57. Ogawa T, Asai Y, Tamai R et al. Natural killer cell activities of synbiotic Lactobacillus casei ssp. casei in conjunction with dextran. Clin. Exp. Immunol. 143(1), 103-109 (2006).
58. Escamilla J, Lane MA, Maitin V. Cell-free supernatants from probiotic Lactobacillus casei and Lactobacillus rhamnosus GG decrease colon cancer cell invasion in vitro. Nutr. Cancer 64(6), 871-878 (2012).
59. Kingma SD, Li N, Sun F et al. Lactobacillus johnsonii N6.2 stimulates the innate immune response through Toll-like receptor 9 in Caco-2 cells and increases intestinal crypt Paneth cell number in biobreeding diabetes-prone rats. J. Nutr. 141(6), 1023-1028 (2011).
60. Paolillo R, Romano Carratelli C, Sorrentino S et al. Immunomodulatory effects of Lactobacillus plantarum on human colon cancer cells. Int. Immunopharmacol. 9(11), 1265-1271 (2009).
61. Li W, Tang W, Ji J et al. Characterization of a novel polysaccharide with anti-colon cancer activity from Lactobacillus helveticus MB2-1. Carbohydr. Res. 411, 6-14 (2015).
62. Li W, Xia X, Tang W et al. Structural characterization and anticancer activity of cell-bound exopolysaccharide from Lactobacillus helveticus MB2-1. J. Agric. Food Chem. 63(13), 3454-3463 (2015).
63. Deepak V, Pandian SR, Sivasubramaniam SD et al. Optimization of anticancer exopolysaccharide production from probiotic Lactobacillus acidophilus by response surface methodology. Prep. Biochem. Biotechnol. (2015) (Epub ahead of print).
64. Wang J, Zhao X, Yang Y, Zhao A, Yang Z. Characterization and bioactivities of an exopolysaccharide produced by Lactobacillus plantarum YW32. Int. J. Biol. Macromol. 74, 119-126 (2015).
65. Soltan Dallal MM, Mojarrad M, Baghbani F et al. Effects of probiotic Lactobacillus acidophilus and Lactobacillus casei on colorectal tumor cells activity (CaCo-2). Arch. Iran. Med. 18(3), 167-172 (2015).
66. Zhang M, Fan X, Fang B et al. Effects of Lactobacillus salivarius Ren on cancer prevention and intestinal microbiota in 1,2-dimethylhydrazine-induced rat model. J. Microbiol. 53(6), 398-405 (2015).
67. Tsai TL, Li AC, Chen YC et al. Antimicrobial peptide m2163 or m2386 identified from Lactobacillus casei ATCC 334 can trigger apoptosis in the human colorectal cancer cell line SW480. Tumour Biol. 36(5), 3775-3789 (2015).
68. Tuo Y, Jiang S, Qian F et al. Short communication. Antiproliferative effect of 8 different Lactobacillus strains on K562 cells. J. Dairy Sci. 98(1), 106-110 (2015).
69. Hu P, Song W, Shan Y et al. Lactobacillus paracasei subsp. paracasei M5L induces cell cycle arrest and calreticulin translocation via the generation of reactive oxygen species in HT-29 cell apoptosis. Food Funct. 6(7), 2257-2265 (2015).
70. Nami Y, Abdullah N, Haghshenas B et al. Probiotic potential and biotherapeutic effects of newly isolated vaginal Lactobacillus acidophilus 36YL strain on cancer cells. Anaerobe 28, 29-36 (2014).
71. Sadeghi-Aliabadi H, Mohammadi F, Fazeli H, Mirlohi M. Effects of Lactobacillus plantarum A7 with probiotic potential on colon cancer and normal cells proliferation in comparison with a commercial strain. Iran. J. Basic Med. Sci. 17(10), 815-819 (2014).
72. Wang SM, Zhang LW, Fan RB et al. Induction of HT-29 cells apoptosis by lactobacilli isolated from fermented products. Res. Microbiol. 165(3), 202-214 (2014).
73. Kandasamy M, Bay BH, Lee YK, Mahendran R. Lactobacilli secreting a tumor antigen and IL15 activates neutrophils and dendritic cells and generates cytotoxic T lymphocytes against cancer cells. Cell Immunol. 271(1), 89-96 (2011).
74. Lim BK, Mahendran R, Lee YK, Bay BH. Chemopreventive effect of Lactobacillus rhamnosus on growth of a subcutaneously implanted bladder cancer cell line in the mouse. Jpn J. Cancer Res. 93(1), 36-41 (2002).
75. Takagi A, Matsuzaki T, Sato M et al. Enhancement of natural killer cytotoxicity delayed murine carcinogenesis by a probiotic microorganism. Carcinogenesis 22(4), 599-605 (2001).
76. Hu J, Wang C, Ye L et al. Anti-tumour immune effect of oral administration of Lactobacillus plantarum to CT26 tumourbearing mice. J. Biosci. 40(2), 269-279 (2015).
77. Aragon F, Carino S, Perdigon G, De Moreno De Leblanc A. Inhibition of growth and metastasis of breast cancer in mice by milk fermented with Lactobacillus casei CRL 431. J. Immunother. 38(5), 185-196 (2015).
78. Kassayova M, Bobrov N, Strojny L et al. Preventive effects of probiotic bacteria Lactobacillus plantarum and dietary fiber in chemically-induced mammary carcinogenesis. Anticancer Res. 34(9), 4969-4975 (2014).
79. Kawase M, He F, Miyazawa K et al. Orally administered heat-killed Lactobacillus gasseri TMC0356 can upregulate cell-mediated immunity in senescence-accelerated mice. FEMS Microbiol. Lett. 326(2), 125-130 (2012).
80. Yoda K, He F, Kawase M, Miyazawa K, Hiramatsu M. Oral administration of Lactobacillus gasseri TMC0356 stimulates peritoneal macrophages and attenuates general symptoms caused by enteropathogenic Escherichia coli infection. J. Microbiol. Immunol. Infect. 47(2), 81-86 (2014).
81. Murosaki S, Yamamoto Y, Ito K et al. Heat-killed Lactobacillus plantarum L-137 suppresses naturally fed antigen-specific IgE production by stimulation of IL-12 production in mice. J. Allergy Clin. Immunol. 102(1), 57-64 (1998).
82. Murosaki S, Muroyama K, Yamamoto Y, Yoshikai Y. Antitumor effect of heat-killed Lactobacillus plantarum L-137 through restoration of impaired interleukin-12 production in tumor-bearing mice. Cancer Immunol. Immunother. 49(3), 157-164 (2000).
83. Maroof H, Hassan ZM, Mobarez AM, Mohamadabadi MA. Lactobacillus acidophilus could modulate the immune response against breast cancer in murine model. J. Clin. Immunol. 32(6), 1353-1359 (2012).
84. Imani Fooladi AA, Yazdi MH, Pourmand MR et al. Th1 cytokine production induced by Lactobacillus acidophilus in BALB/c mice bearing transplanted breast tumor. Jundishapur J. Microbiol. 8(4), e17354 (2015).
85. Khazaie K, Zadeh M, Khan MW et al. Abating colon cancer polyposis by Lactobacillus acidophilus deficient in lipoteichoic acid. Proc. Natl Acad. Sci. USA 109(26), 10462-10467 (2012).
86. Abd El Ghany K, Hamouda R, Abd Elhafez E et al. A potential role of Lactobacillus acidophilus LA1 and its exopolysaccharides on cancer cells in male albino mice. Biotechnol. Biotechnol. Equip. 1-7 (2015) (Epub ahead of print).
87. Salva S, Marranzino G, Villena J et al. Probiotic Lactobacillus strains protect against myelosuppression and immunosuppression in cyclophosphamide-treated mice. Int. Immunopharmacol. 22(1), 209-221 (2014).
88. Yazdi MH, Mahdavi M, Setayesh N et al. Selenium nanoparticle-enriched Lactobacillus brevis causes more efficient immune responses in vivo and reduces the liver metastasis in metastatic form of mouse breast cancer. Daru 21(1), 33 (2013).
89. Kato I, Endo K, Yokokura T. Effects of oral administration of Lactobacillus casei on antitumor responses induced by tumor resection in mice. Int. J. Immunopharmacol. 16(1), 29-36 (1994).
90. Aso Y, Akazan H. Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer. BLP Study Group. Urol. Int. 49(3), 125-129 (1992).
91. Matsuzaki T. Immunomodulation by treatment with Lactobacillus casei strain Shirota. Int. J. Food Microbiol. 41(2), 133-140 (1998).
92. Matsuzaki T, Yokokura T, Azuma I. Anti-tumour activity of Lactobacillus casei on Lewis lung carcinoma and line-10 hepatoma in syngeneic mice and guinea pigs. Cancer Immunol. Immunother. 20(1), 18-22 (1985).
93. Kato I, Yokokura T, Mutai M. Induction of tumoricidal peritoneal exudate cells by administration of Lactobacillus casei. Int. J. Immunopharmacol. 7(1), 103-109 (1985).
94. Takahashi T, Kushiro A, Nomoto K et al. Antitumor effects of the intravesical instillation of heat killed cells of the Lactobacillus casei strain Shirota on the murine orthotopic bladder tumor MBT-2. J. Urol. 166(6), 2506-2511 (2001).
95. Abdalla M, Mahdy E, Hussien M et al. Antiproliferative effect of Lactobacillus helveticus and low dose gamma radiation on mammary carcinogenesis. Int. J. Biochem. Biotechnol. 2(10), 497-503 (2013).
96. De Moreno De Leblanc A, Matar C, Theriault C, Perdigon G. Effects of milk fermented by Lactobacillus helveticus R389 on immune cells associated to mammary glands in normal and a breast cancer model. Immunobiology 210(5), 349-358 (2005).
97. Yazdi MH, Mahdavi M, Kheradmand E, Shahverdi AR. The preventive oral supplementation of a selenium nanoparticle-enriched probiotic increases the immune response and lifespan of 4T1 breast cancer bearing mice. Arzneimittelforschung 62(11), 525-531 (2012).
98. Lakritz JR, Poutahidis T, Levkovich T et al. Beneficial bacteria stimulate host immune cells to counteract dietary and genetic predisposition to mammary cancer in mice. Int. J. Cancer 135(3), 529-540 (2014).
99. Cross ML, Mortensen RR, Kudsk J, Gill HS. Dietary intake of Lactobacillus rhamnosus HNOO1 enhances production of both Th1 and Th2 cytokines in antigenprimed mice. Med. Microbiol. Immunol. 191(1), 49-53 (2002).
100. Takeda K, Suzuki T, Shimada SI et al. Interleukin-12 is involved in the enhancement of human natural killer cell activity by Lactobacillus casei Shirota. Clin. Exp. Immunol. 146(1), 109-115 (2006).
101. Di Caro S, Tao H, Grillo A et al. Effects of Lactobacillus GG on genes expression pattern in small bowel mucosa. Dig. Liver Dis. 37(5), 320-329 (2005).
102. Aso Y, Akaza H, Kotake T et al. Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. The BLP Study Group. Eur. Urol. 27(2), 104-109 (1995).
103. Sawamura A, Yamaguchi Y, Toge T et al. Enhancement of immuno-activities by oral administration of Lactobacillus casei in colorectal cancer patients. Biotherapy 8, 1567-1572 (1994).
104. Okawa T, Niibe H, Arai T et al. Effect of LC9018 combined with radiation therapy on carcinoma of the uterine cervix. A Phase III, multicenter, randomized, controlled study. Cancer 72(6), 1949-1954 (1993).
105. Naito S, Koga H, Yamaguchi A et al. Prevention of recurrence with epirubicin and Lactobacillus casei after transurethral resection of bladder cancer. J. Urol. 179(2), 485-490 (2008).
106. Nowak A, Kuberski S, Libudzisz Z. Probiotic lactic acid bacteria detoxify N-nitrosodimethylamine. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess. 31(10), 1678-1687 (2014).
107. Walia S, Kamal R, Kanwar SS, Dhawan DK. Cyclooxygenase as a target in chemoprevention by probiotics during 1,2-dimethylhydrazine induced colon carcinogenesis in rats. Nutr. Cancer 67(4), 603-611 (2015).
108. Mozaffari Namin B, Daryani NE, Mirshafiey A et al. Effect of probiotics on the expression of Barrett's esophagus biomarkers. J. Med. Microbiol. 64(Pt 4), 348-354 (2015).
109. Ryan KA, O'hara AM, Van Pijkeren JP et al. Lactobacillus salivarius modulates cytokine induction and virulence factor gene expression in Helicobacter pylori. J. Med. Microbiol. 58(Pt 8), 996-1005 (2009).
110. Brosman SA. Bacillus Calmette-Guerin immunotherapy. Techniques and results. Urol. Clin. N. Am. 19(3), 557-564 (1992).
111. Asano M, Karasawa E, Takayama T. Antitumor activity of Lactobacillus casei (LC 9018) against experimental mouse bladder tumor (MBT-2). J. Urol. 136(3), 719-721 (1986).
112. Brandau S, Bohle A. Re: antitumor effects of the intravesical instillation of heat killed cells of the Lactobacillus casei strain Shirota on the murine orthotopic bladder tumor MBT-2. J. Urol. 168(1), 199-200; author reply 200 (2002).
113. Seow SW, Rahmat JNB, Mohamed AK et al. Lactobacillus species is more cytotoxic to human bladder cancer cells than Mycobacterium bovis (Bacillus Calmette-Guerin). J. Urol. 168(5), 2236-2239 (2002).
114. Seow SW, Rahmat JN, Bay BH et al. Expression of chemokine/cytokine genes and immune cell recruitment following the instillation of Mycobacterium bovis, bacillus Calmette-Guerin or Lactobacillus rhamnosus strain GG in the healthy murine bladder. Immunology 124(3), 419-427 (2008).
115. Seow SW, Cai S, Rahmat JN et al. Lactobacillus rhamnosus GG induces tumor regression in mice bearing orthotopic bladder tumors. Cancer Sci. 101(3), 751-758 (2010).
116. Morel C, Badell E, Abadie V et al. Mycobacterium bovis BCG-infected neutrophils and dendritic cells cooperate to induce specific T cell responses in humans and mice. Eur J. Immunol. 38(2), 437-447 (2008).
117. Wyszynska A, Kobierecka P, Bardowski J, Jagusztyn-Krynicka EK. Lactic acid bacteria-20 years exploring their potential as live vectors for mucosal vaccination. Appl. Microbiol. Biotechnol. 99(7), 2967-2977 (2015).
118. Johnston CD, Bannantine JP, Govender R et al. Enhanced expression of codon optimized Mycobacterium avium subsp. paratuberculosis antigens in Lactobacillus salivarius. Front Cell Infect. Microbiol. 4, 120 (2014).
119. Almada G, Haro C, Vintini E, Medina M. Safety of a nasal vaccine against Streptococcus pneumoniae using heat-killed Lactobacillus casei as adjuvant. Immunobiology 220(1), 109-116 (2015).
120. Shibasaki S, Karasaki M, Tafuku S et al. Oral immunization against candidiasis using Lactobacillus casei displaying enolase 1 from Candida albicans. Sci. Pharm. 82(3), 697-708 (2014).
121. Mohamadzadeh M, Duong T, Sandwick SJ et al. Dendritic cell targeting of Bacillus anthracis protective antigen expressed by Lactobacillus acidophilus protects mice from lethal challenge. Proc. Natl Acad. Sci. USA 106(11), 4331-4336 (2009).
122. Zhang X, Hu S, Du X et al. et al. Heterologous expression of carcinoembryonic antigen in Lactococcus lactis via LcsB-mediated surface displaying system for oral vaccine development. J. Microbiol. Immunol. Infect. doi:10.1016/j. jmii.2014.11.009 (2014) (Epub ahead of print).
123. Kawana K, Adachi K, Kojima S et al. Oral vaccination against HPV E7 for treatment of cervical intraepithelial neoplasia grade 3 (CIN3) elicits E7-specific mucosal immunity in the cervix of CIN3 patients. Vaccine 32(47), 6233-6239 (2014).
124. Fang J, Liao L, Yin H et al. Enhanced bacterial tumor delivery by modulating the EPR effect and therapeutic potential of Lactobacillus casei. J. Pharm. Sci. 103(10), 3235-3243 (2014).
125. Motta JP, Bermudez-Humaran LG, Deraison C et al. Foodgrade bacteria expressing elafin protect against inflammation and restore colon homeostasis. Sci. Transl. Med. 4(158), 158ra144 (2012).
126. Carroll IM, Andrus JM, Bruno-Barcena JM et al. Antiinflammatory properties of Lactobacillus gasseri expressing manganese superoxide dismutase using the interleukin 10-deficient mouse model of colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 293(4), G729-G738 (2007).
127. Viaud S, Daillere R, Boneca IG et al. Gut microbiome and anticancer immune response. Really hot sh∗t! Cell Death Differ. 22(2), 199-214 (2015).